UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 47

Sortiert nach

Association of T-cell co-regulatory protein expression with clinical outcomes following radical cystectomy for urothelial carcinoma of the bladder

European journal of surgical oncology, 2014-01, Vol.40 (1), p.121-127

2014

Volltextzugriff (PDF)

Association between neuraxial analgesia, cancer progression, and mortality after radical prostatectomy: a large, retrospective matched cohort study

British journal of anaesthesia : BJA, 2014-07, Vol.113 (suppl_1), p.i95-i102

2014

Volltextzugriff (PDF)

Patterns of Recurrence Following Primary Radiation Therapy for Prostate Cancer Using C-11 Choline Positron Emission Tomography/Computed Tomography: Unique Identification of Sites of Recurrence Impacting Clinical Management

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.S112-S112

2016

Volltextzugriff (PDF)

Intraoperative application of platelet-rich plasma to the neurovascular bundles during radical prostatectomy: A prospective clinical trial

European urology open science (Online), 2020-07, Vol.19, p.e769

2020

Volltextzugriff (PDF)

PO-0870: Fitting data of relapse-free survival after postprostatectomy RT with a comprehensive TCP model

Radiotherapy and oncology, 2016-04, Vol.119, p.S416-S416

2016

Volltextzugriff (PDF)

Discovery of a genomic classifier for predicting clinically aggressive luminal bladder tumors with higher rates of pathological upstaging

European urology open science (Online), 2020-07, Vol.19, p.e822

2020

Volltextzugriff (PDF)

Assessing the impact of salvage radiation therapy field after radical prostatectomy: A long-term analysis from a large multi-institutional series

European urology open science (Online), 2020-07, Vol.19, p.e1060-e1061

2020

Volltextzugriff (PDF)

Assessing the optimal timing of salvage radiation therapy administration after radical prostatectomy: A stage-specific analysis from a large multi-institutional series

European urology open science (Online), 2020-07, Vol.19, p.e1056-e1057

2020

Volltextzugriff (PDF)

Cure without toxicity: Development of a novel model predicting trifecta outcomes after salvage radiation therapy for recurrent prostate cancer after radical prostatectomy

European urology open science (Online), 2020-07, Vol.19, p.e1385

2020

Volltextzugriff (PDF)

A1197 - Survival patterns based on site-specific visceral metastasis in metastatic prostate cancer patients: Are outcomes of visceral metastases the same?

European urology, 2023-02, Vol.83, p.S1731-S1731

2023

Volltextzugriff (PDF)

Survival patterns based on site-specific visceral metastasis in metastatic prostate cancer patients: Are outcomes of visceral metastases the same?

European urology, 2023-02, Vol.83, p.S1731

2023

Volltextzugriff (PDF)

Initial PSA (iPSA) and Radiation Dose Predict for an Undetectable PSA following 3DCRT or IMRT for Low-intermediate Risk Prostate Cancer

International journal of radiation oncology, biology, physics, 2009, Vol.75 (3), p.S313-S313

2009

Volltextzugriff (PDF)

Perioperative morbidity of surgical metastasectomy for renal cell carcinoma: An international multicenter study

European urology, 2022-02, Vol.81, p.S578-S579

2022

Volltextzugriff (PDF)

P268 - Oncologic outcomes in patients with variant histologies of upper tract urothelial cancer: Results from an international multicenter cohort

European urology, 2024-03, Vol.85, p.S369-S370

2024

Volltextzugriff (PDF)

Oncologic outcomes in patients with variant histologies of upper tract urothelial cancer: Results from an international multicenter cohort

European urology, 2024-03, Vol.85, p.S369-S370

2024

Volltextzugriff (PDF)

Efficacy of intravesical nadofaragene firadenovec-vncg for patients with Bacillus Calmette-Guérin-unresponsive non-muscle-invasive bladder cancer: 36-month follow-up from a phase 3 trial

European urology, 2024-03, Vol.85, p.S1492-S1493

2024

Volltextzugriff (PDF)

A0583 - Efficacy of intravesical nadofaragene firadenovec-vncg for patients with Bacillus Calmette-Guérin-unresponsive non-muscle-invasive bladder cancer: 36-month follow-up from a phase 3 trial

European urology, 2024-03, Vol.85, p.S1492-S1493

2024

Volltextzugriff (PDF)

Luminal primary muscle-invasive bladder cancer patients are less likely to benefit from platinum-based neoadjuvant chemotherapy

European urology, 2021-06, Vol.79, p.S1156

2021

Volltextzugriff (PDF)

Prognostic impact of different Gleason patterns within grade group 4 prostate cancer in radical prostatectomy specimens

European urology, 2021-06, Vol.79, p.S1548-S1549

2021

Volltextzugriff (PDF)

Clinical significance of tumor location for ureteroscopic tumor grading in upper tract urothelial carcinoma

European urology, 2022-02, Vol.81, p.S460-S461

2022

Volltextzugriff (PDF)

Development and validation of a novel nomogram predicting long-term progression in patients treated with early salvage radiation therapy after radical prostatectomy: The key role of PSA kinetics

European urology, 2022-02, Vol.81, p.S287-S288

2022

Volltextzugriff (PDF)

Assessing the effect of concomitant hormonal therapy on severe toxicity in patients treated with post-prostatectomy radiation therapy: Results from a large, multi-institutional study

European urology, 2021-06, Vol.79, p.S1661-S1662

2021

Volltextzugriff (PDF)

The key role of PSA doubling time in patients treated with salvage radiation therapy after radical prostatectomy: Implications for the extent of radiation and the concomitant use of hormonal therapy

European urology, 2021-06, Vol.79, p.S1669-S1670

2021

Volltextzugriff (PDF)

What is the optimal duration of hormonal treatment during salvage radiotherapy in men with pN1 Prostate Cancer? Results form a large Multi-Institutional series

European urology, 2021-06, Vol.79, p.S1728-S1729

2021

Volltextzugriff (PDF)

Comparison of salvage radiation therapy delivered for PSA persistence versus PSA relapse after radical prostatectomy: How is the outcome changing?

European urology, 2021-06, Vol.79, p.S1663-S1664

2021

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(47)

Sprache

Englisch
(47)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(6)
Life Sciences & Biomedicine
(6)
Male
(6)
Prostatectomy
(6)
Science & Technology
(6)
Middle Aged
(5)
Prognosis
(5)
Prostate Cancer
(5)
Prostatic Neoplasms - Mortality
(5)
Urological Surgery
(5)
Urology
(5)
Aged
(4)
Care And Treatment
(4)
Hematology, Oncology And Palliative Medicine
(4)
Kaplan-Meier Estimate
(4)
Multivariate Analysis
(4)
Oncology
(4)
Patient Outcomes
(4)
Prostatic Neoplasms - Pathology
(4)
Regression Analysis
(4)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Ingenta Connect
(38)
Elsevier ScienceDirect Journals Complete
(34)
EZB Electronic Journals Library
(13)
IngentaConnect Journals
(11)
MEDLINE
(6)
Journals@Ovid
(5)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(4)
Nature Journals
(4)

3 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Association of T-cell co-regulatory protein expression with clinical outcomes following radical cystectomy for urothelial carcinoma of the bladder

Association between neuraxial analgesia, cancer progression, and mortality after radical prostatectomy: a large, retrospective matched cohort study

Patterns of Recurrence Following Primary Radiation Therapy for Prostate Cancer Using C-11 Choline Positron Emission Tomography/Computed Tomography: Unique Identification of Sites of Recurrence Impacting Clinical Management

Intraoperative application of platelet-rich plasma to the neurovascular bundles during radical prostatectomy: A prospective clinical trial

PO-0870: Fitting data of relapse-free survival after postprostatectomy RT with a comprehensive TCP model

Discovery of a genomic classifier for predicting clinically aggressive luminal bladder tumors with higher rates of pathological upstaging

Assessing the impact of salvage radiation therapy field after radical prostatectomy: A long-term analysis from a large multi-institutional series

Assessing the optimal timing of salvage radiation therapy administration after radical prostatectomy: A stage-specific analysis from a large multi-institutional series

Cure without toxicity: Development of a novel model predicting trifecta outcomes after salvage radiation therapy for recurrent prostate cancer after radical prostatectomy

A1197 - Survival patterns based on site-specific visceral metastasis in metastatic prostate cancer patients: Are outcomes of visceral metastases the same?

Survival patterns based on site-specific visceral metastasis in metastatic prostate cancer patients: Are outcomes of visceral metastases the same?

Initial PSA (iPSA) and Radiation Dose Predict for an Undetectable PSA following 3DCRT or IMRT for Low-intermediate Risk Prostate Cancer

Perioperative morbidity of surgical metastasectomy for renal cell carcinoma: An international multicenter study

P268 - Oncologic outcomes in patients with variant histologies of upper tract urothelial cancer: Results from an international multicenter cohort

Oncologic outcomes in patients with variant histologies of upper tract urothelial cancer: Results from an international multicenter cohort

Efficacy of intravesical nadofaragene firadenovec-vncg for patients with Bacillus Calmette-Guérin-unresponsive non-muscle-invasive bladder cancer: 36-month follow-up from a phase 3 trial

A0583 - Efficacy of intravesical nadofaragene firadenovec-vncg for patients with Bacillus Calmette-Guérin-unresponsive non-muscle-invasive bladder cancer: 36-month follow-up from a phase 3 trial

Luminal primary muscle-invasive bladder cancer patients are less likely to benefit from platinum-based neoadjuvant chemotherapy

Prognostic impact of different Gleason patterns within grade group 4 prostate cancer in radical prostatectomy specimens

Clinical significance of tumor location for ureteroscopic tumor grading in upper tract urothelial carcinoma

Development and validation of a novel nomogram predicting long-term progression in patients treated with early salvage radiation therapy after radical prostatectomy: The key role of PSA kinetics

Assessing the effect of concomitant hormonal therapy on severe toxicity in patients treated with post-prostatectomy radiation therapy: Results from a large, multi-institutional study

The key role of PSA doubling time in patients treated with salvage radiation therapy after radical prostatectomy: Implications for the extent of radiation and the concomitant use of hormonal therapy

What is the optimal duration of hormonal treatment during salvage radiotherapy in men with pN1 Prostate Cancer? Results form a large Multi-Institutional series

Comparison of salvage radiation therapy delivered for PSA persistence versus PSA relapse after radical prostatectomy: How is the outcome changing?

Suchergebnisse filtern